Updated Monday 3rd of January 2022 04:35:09 AM

electroCore Inc. Common Stock

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey.
ROE -53.120
EPS -0.352
Free Cash Flow$
Health Care
Biotechnology: Electromedical & Electrotherapeutic Apparatus

Top gainers today
Top losers today